TBA Law Blog


Posted by: Stacey Shrader Joslin on Jun 13, 2024

The U.S. Supreme Court ruled in a unanimous decision today that a group of anti-abortion doctors did not have standing to challenge new rules related to mifepristone, one of two drugs commonly used in medication abortion. The decision overturns a ruling by the U.S. 5th Circuit Court of Appeals, which had made it more difficult to obtain the drug. The opinion did not address any underlying regulatory or safety issues raised by the group, only finding that the doctors did not show they had personally been harmed by the government’s rules. In related news, Reuters reports that another case from three Republican-led states is still working its way through the appeals process and if taken up by the court could test the legitimacy of the rule.

In another decision released today, the court overturned a lower court’s ruling ordering Starbucks to reinstate seven Memphis-based employees terminated amid a unionization drive. The justices rejected a “more lenient test” used by the lower court to determine the employees had to be reinstated. Instead, it directed courts to use a more stringent, four-factor test applied in other contexts. Read more about both decisions from The Hill.